AKBA Insider Trading

Insider Ownership Percentage: 4.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $300,597.66

Akebia Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Akebia Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Akebia Therapeutics Share Price & Price History

Current Price: $0.90
Price Change: Price Decrease of -0.0123 (-1.35%)
As of 06/24/2024 03:58 PM ET

This chart shows the closing price history over time for AKBA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Akebia Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/29/2024John P. ButlerCEOSell46,570$1.58$73,580.602,044,580View SEC Filing Icon  
2/29/2024Michel DahanCOOSell8,661$1.58$13,684.38706,932View SEC Filing Icon  
2/29/2024Nicole R HadasSVPSell5,974$1.58$9,438.92663,259View SEC Filing Icon  
2/27/2024John P. ButlerCEOSell37,733$1.52$57,354.162,091,150View SEC Filing Icon  
2/27/2024Michel DahanCOOSell10,744$1.52$16,330.88715,593View SEC Filing Icon  
2/27/2024Nicole R HadasSVPSell7,411$1.52$11,264.72669,233View SEC Filing Icon  
2/1/2024John P. ButlerCEOSell46,489$1.68$78,101.522,128,883View SEC Filing Icon  
2/1/2024Steven Keith BurkeSVPSell24,311$1.68$40,842.48711,376View SEC Filing Icon  
5/25/2023Michel DahanCOOSell95,478$1.22$116,483.16574,037View SEC Filing Icon  
5/25/2023Nicole R HadasSVPSell63,186$1.22$77,086.92524,344View SEC Filing Icon  
5/16/2023Steven Keith BurkeSVPSell63,567$1.07$68,016.69530,487View SEC Filing Icon  
3/1/2023David A. SpellmanCFOSell7,210$0.88$6,344.80510,050View SEC Filing Icon  
3/1/2023John P. ButlerCEOSell91,868$0.88$80,843.841,568,872View SEC Filing Icon  
3/1/2023Michel DahanCOOSell20,412$0.88$17,962.56269,515View SEC Filing Icon  
3/1/2023Nicole R HadasSVPSell13,034$0.88$11,469.92287,530View SEC Filing Icon  
6/3/2022Steven C GilmanDirectorSell4,567$0.36$1,644.1243,430View SEC Filing Icon  
3/1/2022David A. SpellmanCFOSell803$2.17$1,742.51View SEC Filing Icon  
2/28/2022John P. ButlerCEOSell25,053$2.15$53,863.95View SEC Filing Icon  
2/28/2022Michel DahanCOOSell6,555$2.15$14,093.25View SEC Filing Icon  
2/28/2022Steven Keith BurkeSVPSell7,400$2.15$15,910.00View SEC Filing Icon  
2/28/2022Violetta CotreauCAOSell3,946$2.15$8,483.90View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Akebia Therapeutics (NASDAQ:AKBA)

33.92% of Akebia Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AKBA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Akebia Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2024Jacobs Levy Equity Management Inc.1,637,578$3M0.0%-11.8%0.781%Search for SEC Filing on Google Icon
5/15/2024Lazard Asset Management LLC43,545$79K0.0%N/A0.021%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC5,309,755$9.72M0.0%-23.2%2.536%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.8,225,972$15.05M0.0%+8.1%3.929%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.790,483$1.45M0.0%N/A0.378%Search for SEC Filing on Google Icon
4/18/2024Compass Ion Advisors LLC25,095$46K0.0%N/A0.012%Search for SEC Filing on Google Icon
4/17/2024Cannon Global Investment Management LLC28,000$51K0.1%N/A0.013%Search for SEC Filing on Google Icon
2/15/2024Orchard Capital Management LLC86,826$0.11M0.0%+29.9%0.044%Search for SEC Filing on Google Icon
2/6/2024Sapient Capital LLC200,000$0.25M0.0%N/A0.101%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.22,519$28K0.0%-97.0%0.011%Search for SEC Filing on Google Icon
2/5/2024Eagle Wealth Strategies LLC20,017$25K0.0%N/A0.010%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.866,554$1.08M0.0%-10.2%0.460%Search for SEC Filing on Google Icon
1/31/2024Archer Investment Corp19,800$25K0.0%N/A0.011%Search for SEC Filing on Google Icon
1/30/2024Mackenzie Financial Corp23,159$29K0.0%+37.6%0.012%Search for SEC Filing on Google Icon
1/29/2024Sapient Capital LLC200,000$0.25M0.0%N/A0.106%Search for SEC Filing on Google Icon
1/16/2024Raymond James & Associates29,917$37K0.0%+48.0%0.016%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.152,737$0.17M0.0%+311,608.2%0.081%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC7,223,488$8.23M0.0%-3.2%3.834%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.755,488$0.86M0.0%+14.1%0.401%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC7,460,353$6.82M0.0%-0.3%4.012%Search for SEC Filing on Google Icon
8/3/2023Mackenzie Financial Corp27,199$25K0.0%-34.3%0.015%Search for SEC Filing on Google Icon
7/27/2023Victory Capital Management Inc.661,898$0.61M0.0%+156.8%0.356%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC50,633$46K0.0%-48.3%0.027%Search for SEC Filing on Google Icon
7/27/2023CWA Asset Management Group LLC49,000$45K0.0%+69.0%0.026%Search for SEC Filing on Google Icon
7/19/2023Eudaimonia Partners LLC27,144$25K0.0%+123.5%0.015%Search for SEC Filing on Google Icon
5/15/2023Alerce Investment Management L.P.16,205,119$9.08M12.0%+7.4%8.716%Search for SEC Filing on Google Icon
5/12/2023Mirabella Financial Services LLP140,604$1.83M0.3%N/A0.076%Search for SEC Filing on Google Icon
5/11/2023Icon Wealth Partners LLC50,000$28K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.302,977$0.17M0.0%+152.4%0.163%Search for SEC Filing on Google Icon
5/2/2023Victory Capital Management Inc.257,744$0.14M0.0%+1,200.3%0.140%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC97,854$55K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/15/2023Alerce Investment Management L.P.15,090,119$8.71M10.0%+224.3%8.203%Search for SEC Filing on Google Icon
2/10/2023Orchard Capital Management LLC66,826$39K0.0%-73.5%0.036%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.120,053$69K0.0%-76.5%0.065%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC165,237$52K0.0%-80.5%0.090%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.510,102$0.16M0.0%+124.9%0.277%Search for SEC Filing on Google Icon
10/26/2022Allspring Global Investments Holdings LLC242,866$76K0.0%+43.8%0.132%Search for SEC Filing on Google Icon
10/26/2022Wipfli Financial Advisors LLC200,000$63K0.0%N/A0.109%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.1,989,467$0.70M0.0%-2.0%1.082%Search for SEC Filing on Google Icon
8/5/2022Connor Clark & Lunn Investment Management Ltd.226,770$80K0.0%-51.9%0.124%Search for SEC Filing on Google Icon
7/29/2022Russell Investments Group Ltd.225,640$78K0.0%-11.8%0.123%Search for SEC Filing on Google Icon
7/25/2022Allspring Global Investments Holdings LLC168,942$59K0.0%-51.7%0.092%Search for SEC Filing on Google Icon
7/19/2022Icon Wealth Partners LLC400,132$0.14M0.0%N/A0.218%Search for SEC Filing on Google Icon
5/16/2022Orchard Capital Managment LLC1,762,731$1.27M0.4%+10.6%0.960%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.471,681$0.34M0.0%+17.2%0.257%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP54,370$39K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/5/2022Rice Hall James & Associates LLC513,292$0.37M0.0%+5.6%0.280%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.255,967$0.18M0.0%-19.0%0.139%Search for SEC Filing on Google Icon
4/25/2022Assenagon Asset Management S.A.104,092$75K0.0%N/A0.059%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP2,231,966$5.04M0.1%-3.9%1.276%Search for SEC Filing on Google Icon
2/15/2022Kennedy Capital Management Inc.333,841$0.75M0.0%-9.3%0.191%Search for SEC Filing on Google Icon
2/15/2022Marshall Wace LLP4,475,138$10.11M0.0%-35.8%2.558%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC433,400$0.98M0.1%-25.5%0.248%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC69,015$0.16M0.1%+18.5%0.039%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd13,106$30K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/14/2022Rice Hall James & Associates LLC486,220$1.10M0.0%-14.1%0.278%Search for SEC Filing on Google Icon
2/14/2022Blair William & Co. IL16,599$38K0.0%-27.5%0.009%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.4,432,203$10.02M0.0%-2.9%2.533%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC738,075$1.67M0.0%+9.5%0.422%Search for SEC Filing on Google Icon
2/10/2022Teacher Retirement System of Texas32,286$73K0.0%+37.2%0.018%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.402,416$0.91M0.0%-6.6%0.230%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.258,563$0.58M0.0%-52.1%0.148%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA70,923$0.16M0.0%-9.1%0.041%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP2,593,841$5.86M0.0%+23.8%1.483%Search for SEC Filing on Google Icon
2/8/2022Swiss National Bank364,785$0.82M0.0%+8.5%0.208%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp1,746,054$3.95M0.0%-1.5%0.998%Search for SEC Filing on Google Icon
2/7/2022SG Americas Securities LLC43,176$98K0.0%-61.2%0.025%Search for SEC Filing on Google Icon
2/3/2022Virginia Retirement Systems ET AL111,800$0.25M0.0%-29.6%0.064%Search for SEC Filing on Google Icon
2/3/2022Nisa Investment Advisors LLC356,208$0.71M0.0%-1.7%0.204%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund123,867$0.28M0.0%+42.9%0.071%Search for SEC Filing on Google Icon
1/28/2022Allspring Global Investments Holdings LLC307,912$0.70M0.0%N/A0.176%Search for SEC Filing on Google Icon
1/21/2022Russell Investments Group Ltd.316,047$0.71M0.0%-22.3%0.181%Search for SEC Filing on Google Icon
1/20/2022Ardent Capital Management Inc.168,811$0.38M0.3%N/A0.096%Search for SEC Filing on Google Icon
12/14/2021UBS Asset Management Americas Inc.174,173$0.50M0.0%-12.4%0.100%Search for SEC Filing on Google Icon
11/16/2021Opaleye Management Inc.311,300$0.90M0.2%N/A0.178%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC21,361$62K0.0%N/A0.012%Search for SEC Filing on Google Icon
11/16/2021Maverick Capital Ltd.105,816$0.31M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/16/2021Metropolitan Life Insurance Co NY48,214$0.14M0.0%+72.5%0.028%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System216,225$0.62M0.0%-1.8%0.124%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP6,968,811$20.07M0.1%+69.6%3.983%Search for SEC Filing on Google Icon
11/15/2021Voya Investment Management LLC115,329$0.33M0.0%+8.2%0.066%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP2,095,763$6.04M0.0%-38.5%1.198%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.122,000$0.35M0.0%N/A0.070%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP254,376$0.73M0.1%N/A0.145%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC949,927$2.74M0.0%-48.0%0.543%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC152,300$0.44M0.0%-34.6%0.087%Search for SEC Filing on Google Icon
11/12/2021The Manufacturers Life Insurance Company102,890$0.30M0.0%+8.4%0.059%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG231,365$0.67M0.0%+130.0%0.132%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC3,229,943$9.30M0.0%+10.5%1.846%Search for SEC Filing on Google Icon
11/12/2021E Fund Management Co. Ltd.37,123$0.11M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.430,671$1.24M0.0%+103.8%0.246%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.514,258$1.48M0.0%-83.5%0.295%Search for SEC Filing on Google Icon
11/10/2021Panagora Asset Management Inc.249,815$0.72M0.0%+253.9%0.143%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.448,643$1.29M0.0%-50.8%0.256%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC673,939$1.94M0.0%+13.3%0.385%Search for SEC Filing on Google Icon
11/9/2021Teacher Retirement System of Texas23,527$68K0.0%+38.7%0.013%Search for SEC Filing on Google Icon
11/9/2021Rice Hall James & Associates LLC566,026$1.63M0.1%+2.4%0.324%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC188,357$0.54M0.0%+11.3%0.108%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.14,052,487$40.47M0.0%+6.7%8.051%Search for SEC Filing on Google Icon
11/9/2021Principal Financial Group Inc.539,832$1.55M0.0%-1.5%0.309%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Akebia Therapeutics logo
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Read More on Akebia Therapeutics

Today's Range

Now: $0.90
Low: $0.88
High: $0.94

50 Day Range

MA: $1.20
Low: $0.91
High: $1.49

52 Week Range

Now: $0.90
Low: $0.78
High: $2.48

Volume

3,196,356 shs

Average Volume

3,738,594 shs

Market Capitalization

$188.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Akebia Therapeutics?

Akebia Therapeutics' top insider shareholders include:
  1. John P Butler (CEO)
  2. Michel Dahan (COO)
  3. Steven Keith Burke (SVP)
  4. Nicole R Hadas (SVP)
  5. David A Spellman (CFO)
Learn More about top insider investors at Akebia Therapeutics.

Who are the major institutional investors of Akebia Therapeutics?

Akebia Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 3.93%
  2. Acadian Asset Management LLC — 2.54%
  3. Jacobs Levy Equity Management Inc. — 0.78%
  4. Assenagon Asset Management S.A. — 0.38%
  5. Lazard Asset Management LLC — 0.02%
  6. Cannon Global Investment Management LLC — 0.01%
Learn More about top institutional investors of Akebia Therapeutics stock.

Which institutional investors are selling Akebia Therapeutics stock?

Within the last quarter, AKBA stock was sold by these institutional investors:
  1. Acadian Asset Management LLC
  2. Jacobs Levy Equity Management Inc.
Within the last year, company insiders that have sold Akebia Therapeutics company stock include:
  1. John P Butler (CEO)
  2. Michel Dahan (COO)
  3. Steven Keith Burke (SVP)
  4. Nicole R Hadas (SVP)
Learn More investors selling Akebia Therapeutics stock.

Which institutional investors are buying Akebia Therapeutics stock?

Within the previous quarter, AKBA stock was acquired by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Vanguard Group Inc.
  3. Lazard Asset Management LLC
  4. Cannon Global Investment Management LLC
  5. Compass Ion Advisors LLC
  6. Torno Capital LLC